Anti-SFSWAP monoclonal antibody

Pre-made anti-SFSWAP monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SFSWAP/SFSWAP products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2734-Ab-1/ GM-Tg-hg-IP2734-Ab-2Anti-Human SFSWAP monoclonal antibodyHuman
GM-Tg-rg-IP2734-Ab-1/ GM-Tg-rg-IP2734-Ab-2Anti-Rat SFSWAP monoclonal antibodyRat
GM-Tg-mg-IP2734-Ab-1/ GM-Tg-mg-IP2734-Ab-2Anti-Mouse SFSWAP monoclonal antibodyMouse
GM-Tg-cynog-IP2734-Ab-1/ GM-Tg-cynog-IP2734-Ab-2Anti-Cynomolgus/ Rhesus macaque SFSWAP monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2734-Ab-1/ GM-Tg-felg-IP2734-Ab-2Anti-Feline SFSWAP monoclonal antibodyFeline
GM-Tg-cang-IP2734-Ab-1/ GM-Tg-cang-IP2734-Ab-2Anti-Canine SFSWAP monoclonal antibodyCanine
GM-Tg-bovg-IP2734-Ab-1/ GM-Tg-bovg-IP2734-Ab-2Anti-Bovine SFSWAP monoclonal antibodyBovine
GM-Tg-equg-IP2734-Ab-1/ GM-Tg-equg-IP2734-Ab-2Anti-Equine SFSWAP monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2734-Ab-1/ GM-Tg-hg-IP2734-Ab-2; GM-Tg-rg-IP2734-Ab-1/ GM-Tg-rg-IP2734-Ab-2;
GM-Tg-mg-IP2734-Ab-1/ GM-Tg-mg-IP2734-Ab-2; GM-Tg-cynog-IP2734-Ab-1/ GM-Tg-cynog-IP2734-Ab-2;
GM-Tg-felg-IP2734-Ab-1/ GM-Tg-felg-IP2734-Ab-2; GM-Tg-cang-IP2734-Ab-1/ GM-Tg-cang-IP2734-Ab-2;
GM-Tg-bovg-IP2734-Ab-1/ GM-Tg-bovg-IP2734-Ab-2; GM-Tg-equg-IP2734-Ab-1/ GM-Tg-equg-IP2734-Ab-2
Products NameAnti-SFSWAP monoclonal antibody
Formatmab
Target NameSFSWAP
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SFSWAP monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2734-Ag-1Recombinant multi-species SFSWA/ SFSWAP/ SFRS8 protein


    Target information

    Target IDGM-IP2734
    Target NameSFSWAP
    Gene ID6433,231769,304431,709551,477438,101094454,512326,100062382
    Gene Symbol and Synonyms1190005N23Rik,6330437E22Rik,SFRS8,SFSWAP,Srsf8,SWAP
    Uniprot AccessionQ12872,D3ZTQ1
    Uniprot Entry NameSFSWA_HUMAN,SFSWA_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000061936
    Target ClassificationN/A

    The target: SFSWAP, gene name: SFSWAP, also named as SFRS8, SWAP. This gene encodes a human homolog of Drosophila splicing regulatory protein. This gene autoregulates its expression by control of splicing of its first two introns. In addition, it also regulates the splicing of fibronectin and CD45 genes. Two transcript variants encoding different isoforms have been identified. [provided by RefSeq, May 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.